Can follicular fluid anti-mullerian hormone level be a determinant of pregnancy in women under 35 years of age?

Creative Commons License

Yilmaz T., Tavukcuoglu S., Tasdemir S., Esenkaya S., İREZ T.

International Journal of Women's Health and Reproduction Sciences, cilt.6, sa.1, ss.6-10, 2018 (Scopus) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 6 Sayı: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.15296/ijwhr.2018.03
  • Dergi Adı: International Journal of Women's Health and Reproduction Sciences
  • Derginin Tarandığı İndeksler: Scopus
  • Sayfa Sayıları: ss.6-10
  • Anahtar Kelimeler: Anti-mullerian hormone, Clinical pregnancy, Embryo, Follicular fluid, In vitro fertilization, Oocyte
  • İstanbul Yeni Yüzyıl Üniversitesi Adresli: Evet

Özet

Objectives: The failure of oocyte morphological assessment to predict in vitro fertilization (IVF) outcome has led the researchers to examine biochemical criteria of follicular fluid (FF). Anti-Mullerian hormone (AMH), an important marker of ovarian reserve, is secreted by the granulosa cells. The aim of this study is to investigate the relationship between the FF (AMH) levels and oocyte, embryo quality, fertilization, and clinical pregnancy. Materials and Methods: The FF (AMH) levels of 61 patients (mean age: 33.72 ± 4.82 years; range: 21 to 42 years) were analyzed. The FF (AMH) levels were measured by the quantitative auto-analyzer with an electro-chemiluminescence assay. Results: The FF (AMH) levels in patients under 35 years of age were higher in pregnant women than non-pregnant ones (P<0.01). Conclusion: Our study results showed that the FF (AMH) levels were correlated with the quality of oocyte and embryo and were the predictors of clinical pregnancy in patients younger than 35 years of age.